UroGen Pharma (URGN) Return on Sales [ROS] (2017 - 2026)
UroGen Pharma's Return on Sales [ROS] came in at 0.15% for Q2 2026, up 171.32 percentage points from -171.17% a year earlier and up 39.92 percentage points from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, UroGen Pharma reported Return on Sales [ROS] of -35.32%, up 95.80 percentage points year-over-year; for FY2025, it came in at -113.73%, down 6.67 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of +960.42 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -107.06% in FY2024 (-27.83 pp), -79.23% in FY2023 (+43.58 pp), -122.82% in FY2022 (+69.29 pp) and -192.11% in FY2021 (+882.04 pp).
- The Q2 2026 figure represents the highest quarterly Return on Sales [ROS] in data going back to Q1 2017.
- Year-over-year, Return on Sales [ROS] has increased for three consecutive quarters, with an average year-over-year change of +24.05 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q3 2021 (a gain of 634.99 percentage points), and the weakest in Q2 2025 (a drop of 52.90 percentage points).
- Business Quant data shows URGN's Return on Sales [ROS] at -39.76% (Q1 2026), -50.52% (Q4 2025) and -99.65% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | 0.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.15% |
| Mar 31, 2026 | -39.76% |
| Dec 31, 2025 | -50.52% |
| Sep 30, 2025 | -99.65% |
| Jun 30, 2025 | -171.17% |
| Mar 31, 2025 | -182.26% |
| Dec 31, 2024 | -112.59% |
| Sep 30, 2024 | -69.61% |
| Jun 30, 2024 | -118.27% |
| Mar 31, 2024 | -137.05% |
| Dec 31, 2023 | -62.09% |
| Sep 30, 2023 | -64.74% |
| Jun 30, 2023 | -72.77% |
| Mar 31, 2023 | -128.23% |
| Dec 31, 2022 | -112.10% |
| Sep 30, 2022 | -112.36% |
| Jun 30, 2022 | -112.71% |
| Mar 31, 2022 | -161.88% |
| Dec 31, 2021 | -123.13% |
| Sep 30, 2021 | -206.50% |
API Access
UroGen Pharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();